Simone L. Verweij

1.1k total citations
14 papers, 713 citations indexed

About

Simone L. Verweij is a scholar working on Immunology, Surgery and Epidemiology. According to data from OpenAlex, Simone L. Verweij has authored 14 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Simone L. Verweij's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Simone L. Verweij is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Simone L. Verweij collaborates with scholars based in Netherlands, United States and United Kingdom. Simone L. Verweij's co-authors include Erik S.G. Stroes, Lotte C.A. Stiekema, Fleur M. van der Valk, Hein J. Verberne, Sophie J. Bernelot Moens, Jeffrey Kroon, Anne Langsted, Børge G. Nordestgaard, Carlijn Kuijk and Renate M. Hoogeveen and has published in prestigious journals such as Scientific Reports, Journal of the American Society of Nephrology and European Heart Journal.

In The Last Decade

Simone L. Verweij

14 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone L. Verweij Netherlands 11 370 208 205 126 111 14 713
Lotte C.A. Stiekema Netherlands 11 366 1.0× 226 1.1× 240 1.2× 126 1.0× 106 1.0× 16 726
Denise D’Andrea United States 14 385 1.0× 166 0.8× 141 0.7× 309 2.5× 147 1.3× 29 862
Sophie J. Bernelot Moens Netherlands 16 301 0.8× 184 0.9× 212 1.0× 182 1.4× 98 0.9× 23 823
Makoto Sugihara Japan 17 182 0.5× 208 1.0× 173 0.8× 60 0.5× 59 0.5× 92 785
Adrian Serone United States 12 217 0.6× 88 0.4× 153 0.7× 173 1.4× 67 0.6× 29 700
Fatima Akdim Netherlands 12 424 1.1× 311 1.5× 78 0.4× 239 1.9× 164 1.5× 24 871
Vincent Fridén Sweden 12 146 0.4× 225 1.1× 116 0.6× 67 0.5× 98 0.9× 14 830
Hector Garcia-Garcia Netherlands 10 280 0.8× 204 1.0× 95 0.5× 86 0.7× 47 0.4× 16 619
Franz Heigl Germany 18 734 2.0× 337 1.6× 163 0.8× 215 1.7× 117 1.1× 49 1.1k
Yoshihiro Sato Japan 14 280 0.8× 248 1.2× 80 0.4× 61 0.5× 47 0.4× 74 714

Countries citing papers authored by Simone L. Verweij

Since Specialization
Citations

This map shows the geographic impact of Simone L. Verweij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone L. Verweij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone L. Verweij more than expected).

Fields of papers citing papers by Simone L. Verweij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone L. Verweij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone L. Verweij. The network helps show where Simone L. Verweij may publish in the future.

Co-authorship network of co-authors of Simone L. Verweij

This figure shows the co-authorship network connecting the top 25 collaborators of Simone L. Verweij. A scholar is included among the top collaborators of Simone L. Verweij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone L. Verweij. Simone L. Verweij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hoogeveen, Renate M., Simone L. Verweij, Yannick Kaiser, et al.. (2021). Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Scientific Reports. 11(1). 4126–4126. 5 indexed citations
2.
Stiekema, Lotte C.A., Koen H.M. Prange, Renate M. Hoogeveen, et al.. (2020). Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a). European Heart Journal. 41(24). 2262–2271. 77 indexed citations
3.
Stiekema, Lotte C.A., Erik S.G. Stroes, Simone L. Verweij, et al.. (2018). Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment. European Heart Journal. 40(33). 2775–2781. 100 indexed citations
4.
Verweij, Simone L., Maurice W.J. de Ronde, Rutger Verbeek, et al.. (2018). Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease. Journal of clinical lipidology. 12(3). 597–603.e1. 29 indexed citations
5.
Verbeek, Rutger, Renate M. Hoogeveen, Anne Langsted, et al.. (2018). Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting. European Heart Journal. 39(27). 2589–2596. 98 indexed citations
6.
Verweij, Simone L., Lotte C.A. Stiekema, Ronak Delewi, et al.. (2018). Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1956–1963. 9 indexed citations
7.
Moens, Sophie J. Bernelot, Simone L. Verweij, Johan G. Schnitzler, et al.. (2017). Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans. Arteriosclerosis Thrombosis and Vascular Biology. 37(5). 969–975. 103 indexed citations
8.
Verweij, Simone L., Raphaël Duivenvoorden, Lotte C.A. Stiekema, et al.. (2017). CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease. Cardiovascular Research. 114(3). 468–475. 42 indexed citations
9.
Valk, Fleur M. van der, Sophie J. Bernelot Moens, Simone L. Verweij, et al.. (2016). Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy. Annals of the Rheumatic Diseases. 75(10). 1848–1851. 24 indexed citations
10.
Valk, Fleur M. van der, Simone L. Verweij, Koos Zwinderman, et al.. (2016). Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging. JACC. Cardiovascular imaging. 9(10). 1198–1207. 75 indexed citations
11.
Valk, Fleur M. van der, Carlijn Kuijk, Simone L. Verweij, et al.. (2016). Increased haematopoietic activity in patients with atherosclerosis. European Heart Journal. 38(6). ehw246–ehw246. 74 indexed citations
12.
Moens, Sophie J. Bernelot, Robert M. Stoekenbroek, Fleur M. van der Valk, et al.. (2016). Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study. BMC Cardiovascular Disorders. 16(1). 237–237. 6 indexed citations
13.
Moens, Sophie J. Bernelot, Simone L. Verweij, Fleur M. van der Valk, et al.. (2016). Arterial and Cellular Inflammation in Patients with CKD. Journal of the American Society of Nephrology. 28(4). 1278–1285. 49 indexed citations
14.
Verweij, Simone L., Fleur M. van der Valk, & Erik S.G. Stroes. (2015). Novel directions in inflammation as a therapeutic target in atherosclerosis. Current Opinion in Lipidology. 26(6). 580–585. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotte C.A. Stiekema Breakdown of academic impact, for papers by Denise D’Andrea Breakdown of academic impact, for papers by Sophie J. Bernelot Moens Breakdown of academic impact, for papers by Makoto Sugihara Breakdown of academic impact, for papers by Adrian Serone Breakdown of academic impact, for papers by Fatima Akdim Breakdown of academic impact, for papers by Vincent Fridén Breakdown of academic impact, for papers by Hector Garcia-Garcia Breakdown of academic impact, for papers by Franz Heigl Breakdown of academic impact, for papers by Yoshihiro Sato
Rankless by CCL
2026